Royalty Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,441	2,378	2,264	2,355	2,237	2,289
Revenue Growth (YoY)	7.80%	5.06%	-3.86%	5.24%	-2.28%	7.87%
Cost of Revenue	-366.18	-295.84	732.46	560.66	904.24	452.84
Gross Profit	2,807	2,674	1,531	1,794	1,333	1,837
Selling, General & Admin	622.27	573.48	236.67	249.75	227.3	182.83
Depreciation & Amortization Expenses	-	-	-	-	5.67	23
Research & Development	441.29	452	2	52	177.11	200.08
Other Operating Expenses	154.78	89.03	-	-	615.83	-
Total Operating Expenses	1,218	1,115	238.67	301.75	1,026	405.91
Operating Income	1,588	1,560	1,292	1,492	307.07	1,431
Interest Income	21.46	33.59	47.34	72.29	78.34	53.54
Interest Expense	-335.95	-307.66	-225.51	-187.19	-187.96	-166.14
Other Non-Operating Income (Expense)	144.16	-111.15	-140.5	-192.03	50.57	-37.93
Total Non-Operating Income (Expense)	-76.34	-385.22	-318.67	-306.93	-59.06	-150.53
Pretax Income	1,359	1,324	1,331	1,700	230.06	1,241
Net Income	827.29	770.95	858.98	1,135	42.83	619.73
Minority Interest in Earnings	531.73	553.25	471.83	565.25	187.23	621.47
Net Income to Common	827.29	770.95	858.98	1,135	42.83	619.73
Net Income Growth	-24.35%	-10.25%	-24.31%	2549.49%	-93.09%	-36.44%
Shares Outstanding (Basic)	464	430	448	448	438	415
Shares Outstanding (Diluted)	526	564	594	603	438	415
Shares Change (YoY)	-4.53%	-4.99%	-1.46%	37.66%	5.59%	-43.84%
EPS (Basic)	1.91	1.79	1.92	2.54	0.10	1.49
EPS (Diluted)	1.91	1.78	1.91	2.53	0.10	1.49
EPS Growth	-22.36%	-6.81%	-24.51%	2430.00%	-93.29%	12.88%
Shares Outstanding	443.63	428.67	445.99	446.69	443.17	432.96
Free Cash Flow	2,612	2,490	2,769	2,988	2,144	2,018
Free Cash Flow Growth	4.91%	-10.08%	-7.32%	39.36%	6.27%	-0.84%
Free Cash Flow Per Share	4.97	4.41	4.66	4.96	4.90	4.86
Dividends Per Share	0.895	0.880	0.840	0.800	0.760	0.680
Dividend Growth	1.70%	4.76%	5.00%	5.26%	11.77%	126.67%
Gross Margin	115.00%	112.44%	67.64%	76.19%	59.58%	80.22%
Operating Margin	65.08%	65.58%	57.10%	63.37%	13.73%	62.49%
Profit Margin	55.69%	55.68%	58.79%	72.20%	10.28%	54.21%
FCF Margin	107.02%	104.69%	122.33%	126.89%	95.83%	88.12%
EBITDA	1,590	1,563	1,292	1,492	307.07	1,431
EBITDA Margin	65.13%	65.74%	57.10%	63.37%	13.73%	62.49%
EBIT	1,588	1,560	1,292	1,492	307.07	1,431
EBIT Margin	65.08%	65.58%	57.10%	63.37%	13.73%	62.49%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q